Showing results (1-10 of 725) with videos related to
Sort By:
Pageof 73
Chinese Journal of Cancer|October 30, 2016
A combination therapy for KRAS-mutant lung cancer by targeting synthetic lethal partners of mutant KRASXiufeng Pang, Mingyao LiuActa Biochimica Et Biophysica Sinica|October 22, 2015
The greedy nature of mutant RAS: a boon for drug discovery targeting cancer metabolism?Jing Lv, Jieqiong Wang, Siyu Chang, et al.The Journal of Pharmacology and Experimental Therapeutics|April 7, 2016
β-Lapachone Induces NAD(P)H:Quinone Oxidoreductase-1- and Oxidative Stress-Dependent Heat Shock Protein 90 Cleavage and Inhibits Tumor Growth and AngiogenesisYougen Wu, Xue Wang, Siyu Chang, et al.Scientific Reports|July 9, 2016
Linifanib (ABT-869) Potentiates the Efficacy of Chemotherapeutic Agents through the Suppression of Receptor Tyrosine Kinase-Mediated AKT/mTOR Signaling Pathways in Gastric CancerJing Chen, Jiawei Guo, Zhi Chen, et al.The Journal of Pharmacology and Experimental Therapeutics|October 30, 2014
The antiparasitic drug, potassium antimony tartrate, inhibits tumor angiogenesis and tumor growth in nonsmall-cell lung cancerBeibei Wang, Weiwei Yu, Jiawei Guo, et al.The Journal of Pharmacology and Experimental Therapeutics|August 11, 2011
Anacardic acid (6-pentadecylsalicylic acid) inhibits tumor angiogenesis by targeting Src/FAK/Rho GTPases signaling pathwayYuanyuan Wu, Lijun He, Li Zhang, et al.The Journal of Pharmacology and Experimental Therapeutics|July 16, 2010
Methyl 2-cyano-3,11-dioxo-18-olean-1,12-dien-30-oate (CDODA-Me), a derivative of glycyrrhetinic acid, functions as a potent angiogenesis inhibitorXiufeng Pang, Li Zhang, Yougen Wu, et al.Organic & Biomolecular Chemistry|November 24, 2015
Design, synthesis and anticancer activities of novel otobain derivativesZhongzhou Li, Hui Su, Weiwei Yu, et al.Organic & Biomolecular Chemistry|August 21, 2014
Total synthesis and biological studies of cryptocin and derivatives of equisetin and fusarisetin ALili Kong, Mingjin Rao, Jinjie Ou, et al.Pageof 73